USA Financial Formulas’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$60.4K Sell
163
-19
-10% -$6.71K 0.01% 213
2026
Q2
$65.3K Sell
182
-57
-24% -$17.4K 0.01% 236
2026
Q1
$59.9K Sell
239
-179
-43% -$44.5K 0.01% 212
2025
Q4
$115K Sell
418
-170
-29% -$46.5K 0.02% 184
2025
Q3
$154K Buy
+588
New +$143K 0.03% 166
2024
Q3
– Sell
-712
Closed -$235K – 371
2024
Q2
$235K Sell
712
-116
-14% -$41K 0.04% 145
2024
Q1
$328K Buy
828
+29
+4% +$10.7K 0.05% 138
2023
Q4
$281K Buy
799
+170
+27% +$60.2K 0.05% 125
2023
Q3
$236K Buy
629
+627
+31,350% +$242K 0.35% 77
2023
Q2
$765 Hold
2
– – ﹤0.01% 393
2023
Q1
$693 Buy
+2
New +$584 ﹤0.01% 324
2022
Q3
$0 Sell
2
-6
-75% -$1.83K ﹤0.01% 430
2022
Q2
$2K Buy
8
+6
+300% +$1.95K ﹤0.01% 224
2022
Q1
$1K Sell
2
-2,978
-100% -$1.17M ﹤0.01% 338
2021
Q4
$1.4M Buy
2,980
+1,184
+66% +$510K 1.2% 43
2021
Q3
$762K Buy
+1,796
New +$757K 0.68% 80
2021
Q1
– Sell
-4,834
Closed -$1.37M – 438
2020
Q4
$1.37M Sell
4,834
-692
-13% -$194K 1.08% 28
2020
Q3
$1.52M Buy
5,526
+3,851
+230% +$1.02M 1.15% 34
2020
Q2
$381K Sell
1,675
-2,533
-60% -$498K 0.28% 53
2020
Q1
$641K Buy
+4,208
New +$648K 0.41% 73
2016
Q4
– Sell
-3,094
Closed -$231K – 361
2016
Q3
$231K Buy
+3,094
New +$246K 0.06% 211

Other funds holding WST

USA Financial Formulas's WST Position: Q3 2026 in Review

USA Financial Formulas reduced its West Pharmaceutical (WST) stake by 10% in Q3 2026, selling an estimated $6.71K and leaving 163 shares worth $60.4K. The position accounts for 0.01% of the portfolio, ranked #213.

USA Financial Formulas first reported a position in WST in Q3 2016 and has held it in 21 quarters since. The position peaked at $1.52M in Q3 2020. 189 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • USA Financial Formulas held 163 shares of West Pharmaceutical worth $60.4K as of Q3 2026.
  • USA Financial Formulas sold 19 West Pharmaceutical shares in Q3 2026, an estimated $6.71K.
  • West Pharmaceutical made up 0.01% of USA Financial Formulas's portfolio in Q3 2026, its #213 holding.
  • USA Financial Formulas first reported a position in West Pharmaceutical in Q3 2016 and has held it in 21 quarters since.
  • USA Financial Formulas's West Pharmaceutical position peaked at $1.52M in Q3 2020.
  • 189 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on USA Financial Formulas's 13F filing for Q3 2026, filed 16 Oct 2026.